These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26253849)

  • 1. Breast cancer subtypes can be determinant in the decision making process to avoid surgical axillary staging: A retrospective cohort study.
    Marrazzo A; Boscaino G; Marrazzo E; Taormina P; Toesca A
    Int J Surg; 2015 Sep; 21():156-61. PubMed ID: 26253849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
    Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
    Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
    Dihge L; Bendahl PO; Rydén L
    Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.
    Mamtani A; Patil S; Van Zee KJ; Cody HS; Pilewskie M; Barrio AV; Heerdt AS; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
    Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
    Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes.
    Zhou W; He Z; Xue J; Wang M; Zha X; Ling L; Chen L; Wang S; Liu X
    PLoS One; 2012; 7(4):e35881. PubMed ID: 22563412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing landscape of axillary surgery: which breast cancer patients may still benefit from complete axillary lymph node dissection?
    McGhan LJ; Dueck AC; Gray RJ; Wasif N; McCullough AE; Pockaj BA
    J Surg Oncol; 2012 Sep; 106(3):254-9. PubMed ID: 22034211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of lymphatic invasion combined with size of primary tumor for predicting sentinel lymph node metastasis in patients with breast cancer.
    Fujii T; Yajima R; Tatsuki H; Suto T; Morita H; Tsutsumi S; Kuwano H
    Anticancer Res; 2015 Jun; 35(6):3581-4. PubMed ID: 26026130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
    Saidi RF; Dudrick PS; Remine SG; Mittal VK
    Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
    Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
    Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
    Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
    Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy.
    Viale G; Maiorano E; Pruneri G; Mastropasqua MG; Valentini S; Galimberti V; Zurrida S; Maisonneuve P; Paganelli G; Mazzarol G
    Ann Surg; 2005 Feb; 241(2):319-25. PubMed ID: 15650643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the likelihood of nonsentinel lymph node metastases in triple negative breast cancer patients with a positive sentinel lymph node: Turkish Federation of Breast Disease Associations protocol MF09-01.
    Ozbas S; Ozmen V; Igci A; Muslumanoglu M; Ozcinar B; Balkan M; Aydogan F; Canda T; Harmancioglu O; Aksaz E; Gulluoglu BM; Kayahan M; Ozaslan C; Canturk NZ; Mersin H; Utkan Z; Kocak S; Ulufi N; Polat AK; Andacoglu O; Soran A
    Clin Breast Cancer; 2012 Feb; 12(1):63-7. PubMed ID: 22130034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer.
    Ding J; Jiang L; Wu W
    Med Sci Monit; 2017 Aug; 23():4102-4108. PubMed ID: 28839123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
    Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
    Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma.
    Chua B; Ung O; Taylor R; Bilous M; Salisbury E; Boyages J
    Cancer; 2001 Oct; 92(7):1769-74. PubMed ID: 11745248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.